Company Overview

Company name: Phylos
Description: Operator of an agricultural genomics company focused on the cannabis industry. The company uses modern molecular genetics and computational biology to offer research and diagnostic tests on cannabis, enabling growers and other players in the supply chain to save money while also providing a superior product.
Year founded: 2014
Parent company:
Industry: Healthcare | Group: Healthcare Technology Systems | Code:
Website: www.phylos.bio
Employees: 40
City: Portland
State: Oregon
Country: United States
Region: Americas

Financial Highlights

Start up capital raised (USD Million): 5.43
Business status: Generating Revenue
Ownership: Privately Held (backing)
Exchange:
Ticker:
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period:
Financing Status: The company raised $4 million of Series C venture funding from Slow Ventures on June 1, 2017, putting the company’s pre-money valuation at $12 million.
Number of active investors:
Profile last updated: 02-Oct-2018
Last known valuation: 16.00
Last known valuation date: 01-Jun-2017